What is ENLV's relative strength rating?

ENLV ranks at the 1th percentile over 1 month, 2th percentile over 3 months, 2th percentile over 6 months, 4th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is ENLV in?

ENLV is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is ENLV in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ENLV benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is ENLV?

ENLV currently shows a 20-day average daily range (ADR%) of 13.4%, a 90-day beta versus the S&P 500 of 0.99. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does ENLV have a seasonal pattern?

TickerStance computes ENLV's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ENLV has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did ENLV last report earnings?

No SEC EDGAR filings are linked to ENLV in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Enlivex Ltd. Ordinary Shares (ENLV) · RS 2

TODAY'S READ · AS OF 2026-08-25

As of 2026-08-25, Enlivex Ltd. Ordinary Shares (ENLV) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 22. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 13.4%, relative volume 0.34×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month2pctile

6 month2pctile

1 year4pctile

Classic2IBD pctile

LDR12leadership

0 of 5 lenses lit · avg RS pctile 4

✓ADR%13.4%!A/DE!RVOL0.34×!$ Vol$619K

COMPUTED · AS OF 2026-08-25

Pattern read

ENLV is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -69.1% / -87.1%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

52.9Neutral

Trend30% weight47.0 Breadth30% weight56.3 Leadership20% weight42.0 Macro20% weight60.3 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

1

3m

2

6m

2

1y

4

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · ENLV

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
ENLV
2RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

GNPXGenprex, Inc. Common Stock2 SBFMSunshine Biopharma Inc.2 ELABPMGC Holdings Inc. Common Stock2 VNRXVolitionRx Limited2

§ Seasonality

10y · since 2022

Best monthJan on averageavg +13.15% · 75% win · n 4

Worst monthApr on averageavg -20.86% · 20% win · n 5

ENLV monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	ENLV Jan avg: 13.15% median: 7.47% win: 75% σ: 21.51% n: 4 2022-04-12 → 2026-07-31	ENLV Feb avg: 6.29% median: 9.99% win: 75% σ: 10.17% n: 4 2022-04-12 → 2026-07-31	ENLV Mar avg: -6.30% median: -14.06% win: 25% σ: 19.50% n: 4 2022-04-12 → 2026-07-31	ENLV Apr avg: -20.86% median: -19.63% win: 20% σ: 22.30% n: 5 2022-04-12 → 2026-07-31	ENLV May avg: -9.53% median: -8.24% win: 0% σ: 6.37% n: 5 2022-04-12 → 2026-07-31	ENLV Jun avg: -3.51% median: 0.28% win: 60% σ: 19.19% n: 5 2022-04-12 → 2026-07-31	ENLV Jul avg: -11.16% median: -5.63% win: 20% σ: 39.11% n: 5 2022-04-12 → 2026-07-31	ENLV Aug avg: -3.91% median: -4.81% win: 25% σ: 21.74% n: 4 2022-04-12 → 2026-07-31 (current)	ENLV Sep avg: -6.17% median: -10.00% win: 25% σ: 27.17% n: 4 2022-04-12 → 2026-07-31	ENLV Oct avg: -8.39% median: -7.44% win: 50% σ: 10.90% n: 4 2022-04-12 → 2026-07-31	ENLV Nov avg: 5.50% median: -0.39% win: 50% σ: 23.78% n: 4 2022-04-12 → 2026-07-31	ENLV Dec avg: 1.94% median: -5.73% win: 50% σ: 32.31% n: 4 2022-04-12 → 2026-07-31

ETF OWNERS

ETFs holding ENLV

ENLV appears in 1 ETF as of May 2026: QQQS at 0.29% weight, $54K notional.

Held by 1 ETFs · $54K across latest filings · largest weight 0.29% (QQQS).

ETFs holding: 1
Total value: $54K
Top 3 concentration: 100.0%
Max weight: QQQS · 0.29%

Top 1 by value, from SEC N-PORT-P filings dated May 2026.

ETFs holding ENLV ranked by value
ETF	Weight	Value	Δ
QQQS	0.29%	$54K	−0.27 pp

QQQS trimmed −0.27 pp

As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.

Public attention · ENLV

Is the crowd watching?

35/ 100 · vs its own 90-day norm▼ 8 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float32.2Mshares

Shares out17.5Mshares

Market cap$26.6MNano Cap

FAQ

Frequently asked questions

What is ENLV's relative strength rating?: ENLV ranks at the 1th percentile over 1 month, 2th percentile over 3 months, 2th percentile over 6 months, 4th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is ENLV in?: ENLV is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is ENLV in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ENLV benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is ENLV?: ENLV currently shows a 20-day average daily range (ADR%) of 13.4%, a 90-day beta versus the S&P 500 of 0.99. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does ENLV have a seasonal pattern?: TickerStance computes ENLV's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ENLV has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Enlivex Ltd. Ordinary Shares (ENLV) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

ETFs holding ENLV

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

Enlivex Ltd. Ordinary Shares (ENLV) — Stance & relative strength

ENLV is not confirmed as a leader. 2 is not yet a leadership-grade RS read, Market Stance is 52.9

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding ENLV

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?